Klara Dickinson-Eason
2016
In 2016, Klara Dickinson-Eason earned a total compensation of $705.5K as SVP, Chief Regulatory Office at Anthera Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $85,386 |
|---|---|
| Option Awards | $287,661 |
| Salary | $332,500 |
| Total | $705,547 |
Dickinson-Eason received $332.5K in salary, accounting for 47% of the total pay in 2016.
Dickinson-Eason also received $85.4K in non-equity incentive plan and $287.7K in option awards.
Rankings
In 2016, Klara Dickinson-Eason's compensation ranked 9,841st out of 14,075 executives tracked by ExecPay. In other words, Dickinson-Eason earned more than 30.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,841 out of 14,075 | 30th |
Division Manufacturing | 3,801 out of 5,486 | 31st |
Major group Chemicals And Allied Products | 1,331 out of 1,900 | 30th |
Industry group Drugs | 1,059 out of 1,543 | 31st |
Industry Pharmaceutical Preparations | 831 out of 1,173 | 29th |
Source: SEC filing on March 16, 2017.
Dickinson-Eason's colleagues
We found five more compensation records of executives who worked with Klara Dickinson-Eason at Anthera Pharmaceuticals in 2016.
2016
Craig Thompson
Anthera Pharmaceuticals
Chief Executive Officer
2016
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2016
William Shanahan
Anthera Pharmaceuticals
Chief Medical Officer
2016
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2016
May Liu
Anthera Pharmaceuticals